Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-17

Clinical Trial Update: Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery [NA]

View source ↗

Summary

The update reports results on the effects and safety of 3% diquafosol ophthalmic solution after cataract surgery in patients with dry eye symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diquafosol (diquafosol tetrasodium)

Snippet

Sponsor: Soonchunhyang University Hospital | Conditions: Dry Eye Syndromes | NA | Status: COMPLETED | Results posted: 2016-10-17